trial

Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia

NCTId NCT07196462
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 100 (estimated)
Sponsored by Vanderbilt University Medical Center
Primary completion 2027-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
100 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2026-01-15
Primary completion
2027-12-31
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
3 Minute iTBS to the L DLPFCOne-Minute, Personalized, DMN Targeted CTBS

Sponsors

Vanderbilt University Medical CenterLead Sponsor

Sites

1 total
Nashville, United States

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2027-12-31
Status
RECRUITING
relationships
The graph out of here
drug
3 Minute iTBS to the L DLPFC
drug
One-Minute, Personalized, DMN Targeted CTBS
drug
lead_sponsor
Vanderbilt University Medical Center
company
indication
rTMS
indication
Psychosis
indication
Psychotic Disorders
indication